The potential reclassification of cannabinoids, particularly at the federal level, is generating considerable anticipation within the market. A shift away from Schedule I status, often considered as outdated and https://sb-bookmarking.com/story20832534/cannabinoid-rescheduling-a-expansion-catalyst